Found 0 matching trials
Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer PHASE2 This phase 2 trial studies how well panitumumab-IRDye800 works in identifyi...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
Sentinel Node Biopsy Alone or With Axillary Dissection After Primary Chemotherapy NA Many doctors believe that breast cancer patients scheduled for pre-operativ...
Show More Location
Multiple Locations
Learn More & Join Trial
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer N/A The purpose of this study is to collect information that may identify peopl...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma PHASE2 Currently, there is no widely used adjuvant treatment available to improve ...
Show More Location
VU Medical Centere
Learn More & Join Trial
Partial Breast Irradiation Without Sentinel Lymph Node Biopsy in Low-Risk Early Breast Cancer PHASE3 This is a multicenter, randomized, phase III non-inferiority trial in women...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer PHASE1 RATIONALE: Studying samples of tumor tissue and blood from patients with ca...
Show More Location
Multiple Locations
Learn More & Join Trial
Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer NA The rationale of the present study is to assess the safety of the minimally...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC NA Head and neck squamous cell carcinoma is the sixth most common malignant tu...
Show More Location
Sun Yat-sen Memorial Hospital
Learn More & Join Trial
Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk Melanoma NA This study is an open-label, pilot study of an autologous tumor cell vaccin...
Show More Location
University of Virginia
Learn More & Join Trial
Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer NA This study is a prospective, open label, single-arm study to examine the pe...
Show More Learn More & Join Trial